Long-term efficacy, survival, and safety of [ 177 Lu-DOTA 0 ,Tyr 3 ]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors
Standard subcutaneous injection sites recommended by oncology and clinical education centers are the same for most subcutaneous drugs and include: Abdomen (belly) avoid a 12 inch circle around the navel
This temporary nature actually adds to its safety profile, as it means any unwanted effects aren't permanent
This technology: protects glutathione from degradation in the digestive tract enables its efficient transport through the body increases the stability of the active substance The liposomal form is considered one of the most advanced forms of glutathione supplementation
Davies H, Bignell GR, Cox C, Stephens P, Edkins S et al (2002) Mutations of the BRAF gene in human cancer